[1]
Uzma Chohan et al. 2025. PREVALENCE OF COMPLICATIONS WITH ASSOCIATION OF INCREASED SERUM FERRITIN LEVEL IN THALASSEMIA PATIENTS. NEEDS TO BE MORE FOCUSED. Journal of Population Therapeutics and Clinical Pharmacology. 32, 6 (Jul. 2025), 749–757. DOI:https://doi.org/10.53555/75ff8v06.